Date

Presenter

Title

4月10日

坂本光

米国短期研修の報告

安東恒史
4月17日

4月24日

北之園英明

Cell.

2017

171

103-119

Blood Advances 2018

2534-548

N Engl J Med

2018

378

1189-1199

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

N Engl J Med

2018

378

1107-1120

Blood Advances 2018

2335-346

Blood

2018

131

2846-2855

Blood

2018

131

1846-1857

Blood

2016

127

296-302

Blood

2017

130

2610-2618

N Engl J Med

2018

378

1396-1407

Blood

2015

126

4217

Leuk Res.

2013

37637-40

Lancet Oncol.

2018

19240-248

Cancer Cell.

201833386-400

藤岡真知子

北之園英明

榊智佳
今泉芳孝

5月22日

myeloproliferative neoplasm

Page

Molecular Minimal Residual Disease in Acute Myeloid Leukemia

澤山靖
5月15日

Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation ofVol

クリクラ宮崎泰司
5月8日

to Dictate Enhancer-Promoter Communication and T Cell Fate.

Year波多智子

長井一浩
5月1日

Non-coding Transcription Instructs Chromatin Folding and Compartmentalization

Journal

クリクラ生

Natural killer receptor ligand expression on acute myeloid leukemia impacts survival andrelapse after chemotherapy
MAGIC biomarkers predict long term outcomes for steroid-resistant acute GVHD.
Early detection and evolution of preleukemic clones in therapy-related myeloid
neoplasms following autologous SCT
内科地方会

予行

High-dose dexamethasone vs prednisone for treatment of adult immune
thrombocytopenia: a prospective multicenter randomized trial
Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory
myeloma patients
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
A Phase II Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite)
for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute

一瀬将広

myeloid leukemia (tMDS/AML): a report on 54 patients by the Groupe Francophone Des
Myelodysplasies (GFM).
Inotuzumab ozogamicin in combination with low-intensity chemotherapy

5月29日

古本嵩文

for older patients with Philadelphia chromosome-negative acute lymphoblastic
leukaemia: a single-arm, phase 2 study.

糸永英弘
6月5日

6月12日

Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.

Leukemia.

2018 Mar 1. --佐藤信也

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

N Engl J Med

20183781479-1493

Leukemia.

2018

321147-1156

Nature Medicine 201824497-504

Cancer.

2018

1242740-2747

Blood.

2017

1291380-1388

2018

32413-418

北之園英明

クリクラ生
坂本光

6月26日

on a Pre-mRNA Metabolic Pathway Regulated by DCPS.

田口正剛

安東恒史
6月19日

Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence

藤岡真知子
波多智子

Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity
to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
H3B-8800, an orally available small-molecule splicing modulator
induces lethality in spliceosome-mutant cancers.
Early results of lower dose dasatinib (50 mg daily) as frontline therapy
for newly diagnosed chronic-phase chronic myeloid leukemia.
Safety and efficacy of allogeneic hematopoietic stem cell transplant
after PD-1 blockade in relapsed/refractory lymphoma.

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia. Leukemia.
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes
and other myeloid neoplasms: problem areas.

Br J Haematol.

2018 Jun 19. --